Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres

CardioVascular and Interventional Radiology

Volumn 35, Issue 2, 2012, Pages 334-342

  Paprottka, Philipp M ^a   Hoffmann, Ralf T ^a   Haug, Alexander ^a   Sommer, Wieland H ^a   Raebler, Franziska ^a   Trumm, Christoph G ^a   Schmidt, Gerwin P ^a   Ashoori, Nima ^a   Reiser, Maximilian F ^a   Jakobs, Tobias F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Clinical symptoms; Liver metastases; Neuroendocrine tumors; Radioembolization; SIRT

Indexed keywords

CHROMOGRANIN A; MICROSPHERE; SEROTONIN; YTTRIUM 90;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD LEVEL; CANCER CONTROL; CANCER GROWTH; CANCER RADIOEMBOLIZATION; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HEPATOGRAPHY; HUMAN; LIVER FUNCTION TEST; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; PATIENT ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT RESPONSE; UNRESECTABLE LIVER METASTASIS FROM NEUROENDOCRINE TUMOR;

ABDOMINAL PAIN; ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM DISEASES; EMBOLIZATION, THERAPEUTIC; FATIGUE; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEUROENDOCRINE TUMORS; RADIATION DOSAGE; RETROSPECTIVE STUDIES; YTTRIUM RADIOISOTOPES;

EID: 84862896097     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0248-1     Document Type: Article

References (51)

1. Abrams RA, King D, Wilson JF (1987) Objective response of malignant carcinoid to radiation therapy. Int J Radiat Oncol Biol Physiol 13 (6): 869-873
2. Akerstrom G, Hellman P, Hessman O, Osmak L (2005) Management of midgut carcinoids. J Surg Oncol 89 (3): 161-169
3. Brown KT, Koh BY, Brody LA et al. (1999) Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 10 (4): 397-403
4. Cao CQ, Yan TD, Bester L, Liauw W, Morris DL (2010) Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg 97 (4): 537-543
5. Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G, Falconi M (2011) Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology. doi: 10.1159/000324770
6. Carr BI (2004) Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 10 (2 Suppl 1): S107-S110
7. Chakravarthy A, Abrams RA (1995) Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer 75 (6): 1386-1390
8. Chamberlain RS, Canes D, Brown KT et al. (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 (4): 432-445
9. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA (1998) Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 (1): 88-92; discussion 92-93
10. Coldwell DM, Sewell PE (2005) The expanding role of interventional radiology in the supportive care of the oncology patient: from diagnosis to therapy. Semin Oncol 32 (2): 169-173
11. Delcore R, Friesen SR (1994) Gastrointestinal neuroendocrine tumors. J Am Coll Surg 178 (2): 187-211
12. Duffaud F, Therasse P (2000) New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 87 (12): 881-886
13. Eriksson BK, Larsson EG, Skogseid BM, Lofberg AM, Lorelius LE, Oberg KE (1998) Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83 (11): 2293-2301
14. Gaitan-Gaitan A, Rider WD, Bush RS (1975) Carcinoid tumorcure by irradiation. Int J Radiat Oncol Biol Physiol 1 (1-2): 9-13
15. Gray B, Van Hazel G, Hope M et al. (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (12): 1711-1720
16. Gupta S, Johnson MM, Murthy R et al. (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104 (8): 1590-1602
17. Hibi T, Sano T, Sakamoto Y et al. (2007) Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan. Jpn J Clin Oncol 37 (2): 102-107
18. Jakobs TF, Hoffmann RT, Tatsch K, Trumm C, Reiser MF, Helmberger TK (2007) Developments and perspectives in radioablative techniques. Radiologe 47 (12): 1083-1088
19. Jakobs TF, Hoffmann RT, Tatsch K, Trumm C, Reiser MF (2008) Therapy response of liver tumors after selective internal radiation therapy. Radiologe 48 (9): 839-849
20. Keane TJ, Rider WD, Harwood AR, Thomas GM, Cummings BJ (1981) Whole abdominal radiation in the management of metastatic gastrointestinal carcinoid tumor. Int J Radiat Oncol Biol Physiol 7 (11): 1519-1521
21. Kennedy A, Nag S, Salem R et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Physiol 68 (1): 13-23
22. Kennedy AS, Dezarn WA, McNeillie P et al. (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31 (3): 271-279
23. King J, Quinn R, Glenn DM et al. (2008) Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 113 (5): 921-929
24. Kress O, Wagner HJ, Wied M, Klose KJ, Arnold R, Alfke H (2003) Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors a retrospective single-center analysis. Digestion 68 (2-3): 94-101
25. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC (2006) Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17 (8): 1235-1249; quiz 1250
26. McStay MK, Maudgil D, Williams M et al. (2005) Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy. Radiology 237 (2): 718-726
27. Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79 (4): 813-829
28. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128 (6): 1717-1751
29. Moertel CG, Johnson CM, McKusick MA et al. (1994) The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120 (4): 302-309
30. Murthy R, Nunez R, Szklaruk J et al. (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25 (Suppl 1): S41-S55
31. Musunuru S, Chen H, Rajpal S et al. (2006) Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 141 (10): 1000-1004; discussion 1005
32. Nave H, Mossinger E, Feist H, Lang H, Raab H (2001) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129 (2): 170-175
33. Norton JA (2005) Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. Best Pract Res Clin Gastroenterol 19 (4): 577-583
34. Norton JA, Kerlan RK (2003) Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary. Cancer J 9 (4): 241-243
35. Oberg K (1999) Neuroendocrine gastrointestinal tumors-a condensed overview of diagnosis and treatment. Ann Oncol 10 (Suppl 2): S3-S8
36. Oberg K (2002) Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol 14 (1): 38-45
37. Osborne DA, Zervos EE, Strosberg J et al. (2006) Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 13 (4): 572-581
38. Paprottka PM, Jakobs TF, Reiser MF, Hoffmann RT (2011) Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Interv Radiol 34: 287-294
39. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK (1995) Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169 (1): 36-42; discussion 42-33
40. Reddy PS, Burroughs KD, Hales LM et al. (2007) Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. J Natl Cancer Inst 99 (21): 1623-1633
41. Ruszniewski P, Malka D (2000) Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 62 (Suppl 1): 79-83
42. Safford SD, Coleman RE, Gockerman JP et al. (2004) Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer 101 (9): 1987-1993
43. Salem R, Thurston KG (2006) Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part
44. Comprehensive literature review and future direction. J Vasc Interv Radiol 17 (10): 1571-1593
45. Samlowski WE, Eyre HJ, Sause WT (1986) Evaluation of the response of unresectable carcinoid tumors to radiotherapy. Int J Radiat Oncol Biol Physiol 12 (3): 301-305
46. Sarmiento JM, Que FG (2003) Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 12 (1): 231-242
47. Schupak KD, Wallner KE (1991) The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Int J Radiat Oncol Biol Physiol 20 (3): 489-495
48. Soreide O, Berstad T, Bakka A et al. (1992) Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111 (1): 48-54
49. Therasse E, Breittmayer F, Roche A et al. (1993) Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189 (2): 541-547
50. Veenendaal LM, Borel Rinkes IH, Lips CJ, van Hillegersberg R (2006) Liver metastases of neuroendocrine tumours: early reduction of tumour load to improve life expectancy. World J Surg Oncol 4: 35
51. Yao KA, Talamonti MS, Nemcek A et al. (2001) Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130 (4): 677-682; discussion 682-675